Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-0752 with Tamoxifen or Letrozole in Early Breast Cancer
NCT00756717Phase 4Completed
- Sponsor
- Loyola University Chicago
- Start
- Feb 2008
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of MK-0752 in breast cancer, sponsored by Loyola University Chicago. Started Feb 2008; status: completed.
02
Drugs
MK-0752
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00756717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00756717.